MULTIPARAMETRIC MRI IN PATIENTS WITH LOCALIZED PROSTATE CANCER AFTER RADICAL EXTERNAL RADIOTHERAPY

Author:

Krupina M. V.1,Trofimova T. N.2,Valkov M. Y.3

Affiliation:

1. Northern Medical Clinical Center named after N. A. Semashko Federal Medical-Biological Agency of Russia

2. St. Petersburg State University

3. Northern State Medical University

Abstract

Prostate cancer (PC) is the one of the most common and socially significant malignancies in men. Radiotherapy is currently one of the leading conservative special treatments for a localized and locally advanced PC. The frequency of biochemical recurrence after external beam radiotherapy (EBRT) is high. One of the main problems is a differentiation between local and systemic relapse of PC. Nevertheless, a local recurrence of PC after radiotherapy can occur without increasing PSA. Magnetic resonance imaging (MRI) is a highly informative imaging method, however, currently it is used mostly for the primary diagnosis and is not included into the recommendations for detecting recurrent prostate cancer after treatment. MR-pattern of the local progression after radical EBRT can be similar to that of primary PC. It is also difficult to diagnose local relapse of prostate cancer in some cases. Multiparametric MRI (mpMRI) has the greatest prospects in the diagnosis of local tumor recurrence in prostate cancer patients after radical external beam radiotherapy. The article provides an overview of domestic and foreign literature, in which we attempted to systematize current knowledge about the possibilities of the mpMRI in diagnosing local recurrence after radical EBRT and, based on the results of published studies, identify directions for further application of this approach.

Publisher

Baltic Medical Education Center

Subject

General Medicine

Reference50 articles.

1. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) / под ред. А.Д.Каприна, В.В.Старин ского, Г.В.Петровой. М., 2018. 250 с. [Malignant neoplasms in Russia in 2017 (morbidity and mortality) / ed. by A.D.Kaprin, V.V.Starinsky, G.V.Petrova. Мoscow, 2018, 250 р. (In Russ.)].

2. Клинические рекомендации. Рак предстательной железы / Российское общество урологов. Ассоциация онкологов России. Российское общество онкоурологов. Российское общество клинической онкологии [электронный ресурс]. 2018. Режим доступа: http://cr.rosminzdrav.ru/#!/schema/99. (дата обращения 11.05.2019). [Clinical guidelines. Prostate cancer / Russian Society of Urology. Association of Oncologists of Russia Russian Society of Oncourology. Russian Society of Clinical Oncology [electronic resource]. 2018 (In Russ.)].

3. Состояние онкологической помощи населению России в 2018 году / под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. М., 2019. 236 с. [The state of oncological assistance to the population of Russia in 2018 / ed. by A.D.Kaprin, V.V.Starinsky, G.V.Petrova. Мoscow, 2019, 236 р. (In Russ.)].

4. National Comprehensive Cancer Network. Clinical practice Guidelines in oncology. Prostate cancer [электронный ресурс]. 2019. Режим доступа: www.nccn.org. (дата обращения 11.05.2019).

5. D’Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era // Cancer. 2002. Vol. 95. Р. 281–286.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3